This is still a proof-chain investment: better fidelity must become accepted systems, then recurring capacity contracts, then a broader installed base. The biggest risks are technical validation, slow
TAM realization, concentrated customer demand, and
premium valuation. The balance sheet buys time, but it does not remove the need to prove real commercial usefulness before larger partners or rival modalities capture the economics.